The Predictive Validity of the Dual Diagnosis Capability in Addiction Treatment (DDCAT) Index

2013 ◽  
Vol 9 (2) ◽  
pp. 171-178 ◽  
Author(s):  
Michael Chaple ◽  
Stanley Sacks ◽  
Gerald Melnick ◽  
Karen McKendrick ◽  
Susan Brandau
Keyword(s):  
Predictive Validity ◽  
Dual Diagnosis ◽  
Addiction Treatment

Impulsivity, dual diagnosis, and the structure of motivated behavior in addiction

2008 ◽  
Vol 31 (4) ◽  
pp. 443-444 ◽  
Author(s):  
R. Andrew Chambers
Keyword(s):  
Public Health ◽  
Mental Illness ◽  
Criminal Justice ◽  
Drug Use ◽  
Free Will ◽  
Dual Diagnosis ◽  
Addiction Treatment ◽  
Motivated Behavior

AbstractDefining brain mechanisms that control and adapt motivated behavior will not only advance addiction treatment. It will help society see that addiction is a disease that erodes free will, rather than representing a free will that asks for or deserves consequences of drug-use choices. This science has important implications for understanding addiction's comorbidity in mental illness and reducing associated public health and criminal justice burdens.

scholarly journals Dual diagnosis: a paradigm shift for addiction treatment

2017 ◽  
Vol 5 (9) ◽  
Author(s):  
Rafael A. Gómez Benumea
Keyword(s):  
Substance Use ◽  
Dual Diagnosis ◽  
Mixed Models ◽  
Paradigm Shift ◽  
Addiction Treatment ◽  
Public Health Problem ◽  
Progressive Increase ◽  
The Family ◽  
Drugs And Crime ◽  
Physical Spaces

Dual diagnosis is defined as the comorbidity of a substance use problem and a psychiatric disorder of a person. Drug addiction is a growing public health problem. The United Nations Office on Drugs and Crime (UNODC) reported a progressive increase in the prevalence of a substance use problem from 3.5% to 5.7% from 2008 to 2010; a new increase from 5.7% to 7% between 2010 and 2012, which represents 324 million consumers worldwide. About 60% to 80% of this population presents this dual diagnosis. Prevalence of a personality disorder and a substance use problem comprises 20% to 50%. Prevalence between a depressive disorder and a substance use problem goes from 12% to 88%. Prevalence between anxiety disorders and substance use problems is from 10% to 24% and between bipolar disorder and substance use from 51% to 60%. The importance of the paradigm shift in the addiction treatment includes mixed models of intervention where substance use disorders and comorbid psychiatric disorders are contemplated. They are necessary because they help preventing a relapse, the increase of costs for the family, that the attention gets divided in different physical spaces, the application of different therapeutic techniques and that the pharmacological treatment is not oriented to treat substance use disorder as it is oriented to treat psychiatric comorbidities. Therefore it is necessary to implement a comprehensive vision and a specific approach for each disorder of the patient.

scholarly journals Presence of dual diagnosis between users and non-users of licit and illicit drugs in Brazil

2015 ◽  
Vol 64 (4) ◽  
pp. 288-295 ◽  
Author(s):  
Mariana Bandeira Formiga ◽  
Selene Cordeiro Vasconcelos ◽  
Melyssa Kellyane Cavalcanti Galdino ◽  
Murilo Duarte da Costa Lima
Keyword(s):  
Dual Diagnosis ◽  
Drug Users ◽  
Addiction Treatment ◽  
Illicit Drugs ◽  
Suicide Attempts ◽  
Cross Sectional Study ◽  
Negative Effects ◽  
Cross Sectional ◽  
Group 3 ◽  
Group 2

ABSTRACT Objective Investigate the occurrence of dual diagnosis in users of legal and illegal drugs. Methods It is an analytical, cross-sectional study with a quantitative approach, non-probabilistic intentional sampling, carried out in two centers for drug addiction treatment, by means of individual interviews. A sociodemographic questionnaire, the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and the Mini-International Neuropsychiatric Interview (MINI) were used. Results One hundred and ten volunteers divided into abstinent users (group 1), alcoholics (group 2) and users of alcohol and illicit drugs (group 3). The substances were alcohol, tobacco, crack and marijuana. A higher presence of dual diagnosis in group 3 (71.8%) was observed, which decreased in group 2 (60%) and 37.1% of drug abstinent users had psychiatric disorder. Dual diagnosis was associated with the risk of suicide, suicide attempts and the practice of infractions. The crack consumption was associated with the occurrence of major depressive episode and antisocial personality disorder. Conclusion It was concluded that the illicit drug users had a higher presence of dual diagnosis showing the severity of this clinical condition. It is considered essential that this clinical reality is included in intervention strategies in order to decrease the negative effects of consumption of these substances and provide better quality of life for these people.

Sign in / Sign up

Export Citation Format

Share Document